Rubicon Research Limited (NSE:RUBICON)
751.55
-11.85 (-1.55%)
At close: Mar 5, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 123.82 billion as of March 5, 2026.
Market Cap
123.82B
Enterprise Value
127.98B
Revenue
15.98B
Ranking
n/a
PE Ratio
57.66
Stock Price
751.55
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 123.82B, an increase of 19.64%. That is a compound annual growth rate of 59.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 123.82B | 10.40% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 429.60B |
| J. B. Chemicals & Pharmaceuticals | 333.18B |
| AstraZeneca Pharma India | 219.95B |
| Granules India | 142.37B |
| Jubilant Pharmova | 134.45B |
| Caplin Point Laboratories | 127.32B |
| CORONA Remedies | 96.63B |
| Sanofi India | 88.93B |